Search
Search Results
-
An evaluation of the Australian Community Pharmacy Agreement from a public policy perspective: industry policy cloaked as health policy?
BackgroundA series of Community Pharmacy Agreements (Agreements) between the Federal government and a pharmacy-owners’ body, the Pharmacy Guild of...
-
Value of Data Sharing to Advance Drug Development: A Regulatory Perspective
New tools are needed to evaluate and predict the efficacy and safety of medical products. However, the development of such tools requires...
-
The Evolving Regulatory Paradigm of AI in MedTech: A Review of Perspectives and Where We Are Today
Artificial intelligence (AI)-enabled technologies in the MedTech sector hold the promise to transform healthcare delivery by improving access,...
-
Budget impact analysis of breast cancer medications: a systematic review
BackgroundBreast cancer (BC) is the most common cancer globally among women, with 2,261,419 new cases in 2020; systemic treatment may be...
-
Following the COVID-19 playbook and battling another infodemic: conspiracy beliefs around human monkeypox among the Lebanese population
IntroductionThe non-endemic multicountry outbreak of monkeypox (MPX) has emphasized the issue of conspiracy theories that go viral in times of...
-
Key Steps Toward a Promotional Communications Strategy: Collaboration Best Practices for Teams Creating Promotional Materials and Regulatory Colleagues
A promotional communications strategy is considered early in prescription medical product development by commercial disciplines (e.g.,...
-
Pediatric Market Access: A Qualitative Study
ObjectivesThis qualitative study aims to analyze current PM regulation and market access requirements and proposes potential solutions to mitigate...
-
Delivering Digital Health Solutions that Patients Need: A Call to Action
Digital health solutions have the potential to complement traditional healthcare approaches and deliver improved health outcomes, but there are...
-
Evidence of the Impact of Harm Minimization Programs
People who use drugs (PWUD) account for around 275 million worldwide, with a prevalence of those who inject drugs (PWID) ranging from 0.18–0.30%....
-
Building a Competency Framework to Integrate Inter-disciplinary Precision Medicine Capabilities into the Medical Technology and Pharmaceutical Industry
IntroductionIntegration of precision medicine (PM) competencies across the Medical Technology and Pharmaceutical industry is critical to enable...
-
Economic Evidence for Pharmacist-Led Medicines Use Review and Medicines Reconciliation
Pharmacist-led medicines use review (MUR) and medicines reconciliation (MedRec) aim to identify, resolve, and prevent patient-related drug-related...
-
Economic Evidence for Pharmacist-Led Vaccination Services
Vaccination is one of the most successful and cost-effective public health interventions of all time. Despite the existence of safe and efficacious...
-
Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?
BackgroundAdvanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the...
-
Measuring Structures, Processes, and Outcomes and Generating the Evidence
Pharmaceutical care should enable the best use of medicines at minimized patient risk and justified costs. Given that pharmaceutical care is a...
-
Economic Evidence for Pharmacist Prescribing in Community Pharmacy
The effectiveness of pharmacist interventions is supported by high-level evidence from around the world. Such effectiveness combined with high levels...
-
Health Education, Promotion, and Prevention in LMICs
Health is free from disease and disability. In addition, health is about maintaining individuals’ and communities’ equilibrium in multi-aspects...
-
Pharmacoeconomic Analysis Methods
In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeholders in enlarging the role of economic...
-
Survey of Awareness and Perceptions of Canadians on the Benefits and Risks of Clinical Trials
BackgroundLittle is known about the Canadian public’s perspective regarding clinical trials.
MethodsWe surveyed 1602 Ontario and British Columbia...
-
Building from Patient Experiences to Deliver Patient-Focused Healthcare Systems in Collaboration with Patients: A Call to Action
Patients’ experiences of their diagnosis, condition, and treatment (including the impact on their lives), and their experiences surrounding...
